摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(4-氟苯基)-4,5-二氢-2(3H)-呋喃酮 | 51787-96-3

中文名称
5-(4-氟苯基)-4,5-二氢-2(3H)-呋喃酮
中文别名
4,5-二氢-5-(4-氟苯基)-2(3H)-呋喃酮;gamma-(4-氟苯基)-gamma-丁内酯;4-(4-氟苯基)丁内酯;5-(4-氟苯基)-二氢-2(3H)-呋喃酮;Γ-(4-氟苯基)-Γ-丁内酮
英文名称
5-(4-fluorophenyl)dihydrofuran-2(3H)-one
英文别名
γ-(4-fluorophenyl)-γ-butyrolactone;5-(4-fluorophenyl)dihydrofuran-2-one;5-(p-fluorophenyl)tetrahydro-2-furanone;gamma-(4-Fluorophenyl)-gamma-butyrolactone;5-(4-fluorophenyl)oxolan-2-one
5-(4-氟苯基)-4,5-二氢-2(3H)-呋喃酮化学式
CAS
51787-96-3
化学式
C10H9FO2
mdl
——
分子量
180.179
InChiKey
RMFNZGXVLAUJHF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    324.5±42.0 °C(Predicted)
  • 密度:
    1.2000
  • 稳定性/保质期:
    遵照规定使用和储存,则不会分解。

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    F,Xi
  • WGK Germany:
    3
  • 海关编码:
    29031980
  • 危险类别:
    3
  • 安全说明:
    S29,S9
  • 危险类别码:
    R36/37/38,R11
  • 包装等级:
    I
  • 危险品运输编号:
    UN 2456 3/PG 1
  • 储存条件:
    存放于阴凉干燥处即可。

SDS

SDS:3d03852abbd9d6e070907e1ef75c5566
查看
Name: gamma-(4-Fluorophenyl)-gamma-butyrolactone 98% Material Safety Data Sheet
Synonym: 5-(4-Fluorophenyl)-dihydro-2(3H)-furanon
CAS: 51787-96-3
Section 1 - Chemical Product MSDS Name:gamma-(4-Fluorophenyl)-gamma-butyrolactone 98% Material Safety Data Sheet
Synonym:5-(4-Fluorophenyl)-dihydro-2(3H)-furanon

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
51787-96-3 gamma-(4-Fluorophenyl)-gamma-butyrolac 98 257-422-5
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Absorb spill using an absorbent, non-combustible material such as earth, sand, or vermiculite. Do not use combustible materials such as sawdust. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 51787-96-3: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: viscous
Boiling Point: 129.0 - 131.0 deg C @ 1.00mba
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: > 110 deg C (> 230.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: 1.2000g/cm3
Molecular Formula: C10H9FO2
Molecular Weight: 180.18

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 51787-96-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
gamma-(4-Fluorophenyl)-gamma-butyrolactone - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 51787-96-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 51787-96-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 51787-96-3 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途:医药中间体,具体为五氟利多的中间体。

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-(4-氟苯基)-4,5-二氢-2(3H)-呋喃酮 在 aluminum (III) chloride 、 lithium aluminium tetrahydride 、 氯甲酸乙酯三乙胺 作用下, 以 乙醚氯仿 为溶剂, 反应 16.0h, 生成 五氟利多
    参考文献:
    名称:
    五氟利多的制备方法
    摘要:
    本发明公开了一种五氟利多的制备方法,包括如下步骤:(1)将丁二酸酐和氟苯经付氏反应,再用酸分解,收集式(2)化合物;(2)然后在溶剂中,经还原剂还原,收集式(3)化合物;(3)再与氟苯经Friedel–Crafts反应,收集式(4)化合物,(4)然后与氯甲酸乙酯反应,生成式(5)化合物,(5)与式(ⅩⅦ)所示化合物反应,水解,收集式(6)化合物,(6)用还原剂还原,再对还原产物进行分解,然后收集五氟利多(Ⅰ);本发明收率高,成本低,反应条件温和,路线短,适合工业生产,三废少且易处理,适用于工业生产。反应通式如下。
    公开号:
    CN106187863A
  • 作为产物:
    描述:
    氟苯 在 aluminum (III) chloride 、 C12H14N4*Ir(1+)*2CO*BF4(1-)*C3H7NO 、 氢气 、 potassium hydroxide 作用下, 以 异丙醇 为溶剂, 100.0 ℃ 、5.07 MPa 条件下, 反应 10.0h, 生成 5-(4-氟苯基)-4,5-二氢-2(3H)-呋喃酮
    参考文献:
    名称:
    通过使用NHC-铱配位聚合物作为固体分子催化剂将生物质含氧酸有效氢化为内酯
    摘要:
    事实证明,一系列NHC-铱配位聚合物对于将生物质乙酰丙酸(LA)加氢成γ-戊内酯是一种坚固,高效且可回收的固体分子催化剂。除了在50个大气压的H 2下以0.01 mol%的催化剂负载量获得定量收率外,固体分子催化剂也易于回收并重复使用12次,而选择性和活性没有明显损失。值得注意的是, 在这一重要的转变中,高达1.2×10 5 TON可以实现空前的价值。另外,许多LA同系物,类似物和衍生物具有良好的耐受性,以良好至优异的产率提供了各种有趣的和功能性的内酯,这进一步证实了固体分子催化剂的可行性。
    DOI:
    10.1002/asia.201601537
点击查看最新优质反应信息

文献信息

  • Metal‐Free Synthesis of <i>N</i> ‐Aryl Amides using Organocatalytic Ring‐Opening Aminolysis of Lactones
    作者:Wusheng Guo、José Enrique Gómez、Luis Martínez‐Rodríguez、Nuno A. G. Bandeira、Carles Bo、Arjan W. Kleij
    DOI:10.1002/cssc.201700415
    日期:2017.5.9
    Catalytic ring‐opening of bio‐sourced non‐strained lactones with aromatic amines can offer a straightforward, 100 % atom‐economical, and sustainable pathway towards relevant N‐aryl amide scaffolds. Herein, the first general, metal‐free, and highly efficient N‐aryl amide formation is reported from poorly reactive aromatic amines and non‐strained lactones under mild operating conditions using an organic
    生物来源的非应变内酯与芳族胺的催化开环可以提供一种直接的,100%原子经济且可持续的通往相关N芳基酰胺支架的途径。在此,据报道,在温和的操作条件下,使用有机双环胍催化剂,由反应性较差的芳族胺和非应变的内酯首次形成了无金属且高效的N-芳基酰胺。该协议具有很高的应用潜力,例如与药物相关的分子的形式合成。
  • Efficient hydrogenation of levulinic acid catalysed by spherical NHC-Ir assemblies with atmospheric pressure of hydrogen
    作者:Lingyun Shen、Qingshu Zheng、Yaoqi Liu、Jiajie Wu、Zeye Lu、Tao Tu
    DOI:10.1039/d1gc01513c
    日期:——

    Enhanced catalytic activity towards hydrogenation of levulinic acid to γ-valerolactone under 1 atm H2 was realized by spherical porous self-supported NHC-Ir catalysts.

    通过球形多孔自支撑的NHC-Ir催化剂,在1大气压H2下,实现了对丙酮酸加氢制备γ-戊内酯的增强催化活性。
  • MnO<sub>2</sub>-promoted carboesterification of alkenes with anhydrides: a facile approach to γ-lactones
    作者:Lihuan Wu、Zhenming Zhang、Jianhua Liao、Jianxiao Li、Wanqing Wu、Huanfeng Jiang
    DOI:10.1039/c5cc08867d
    日期:——

    A new radical cyclization method for the formation of C(sp3)–C(sp3) and C–O bonds via MnO2-promoted alkene carboesterification with anhydrides is developed.

    一种新的基于锰促进的烯烃碳酯化反应的C(sp3)-C(sp3)和C-O键的放射状环化方法被开发出来。
  • Catalytic Redox Chain Ring Opening of Lactones with Quinones To Synthesize Quinone-Containing Carboxylic Acids
    作者:Xiao-Long Xu、Zhi Li
    DOI:10.1021/acs.orglett.9b01672
    日期:2019.7.5
    Catalytic ring opening of five- to eight-membered lactones with quinones is achieved through a redox chain mechanism. With low loading of a simple metal triflate Lewis acid catalyst and a chain initiator, C–H bonds of many quinones were efficiently functionalized with carboxylic acid-containing side chains. This method also features 100% atom economy and wide substrate scope. A novel route to the anti-asthma
    五至八元内酯与醌的催化开环是通过氧化还原链机理实现的。在简单的三氟甲磺酸金属路易斯酸催化剂和链引发剂的低负载下,许多醌的C–H键被含羧酸的侧链有效地官能化。该方法还具有100%的原子经济性和广泛的底物范围。开发了一种抗哮喘药Seratrodast的新途径。机理研究表明,氧化还原链反应可能发生碳正离子中间体。
  • Cooperative iodine and photoredox catalysis for direct oxidative lactonization of carboxylic acids
    作者:Thomas Duhamel、Kilian Muñiz
    DOI:10.1039/c8cc08594c
    日期:——
    A new method for the formation of γ- and δ-lactones from carboxylic acids through direct conversion of benzylic C–H to C–O bonds is described. The reaction is conveniently induced by visible light and relies on a mild cooperative catalysis by the combination of molecular iodine and an organic dye.
    描述了一种通过直接将苄基CH键转换为CO键从羧酸形成γ-和δ-内酯的新方法。该反应由可见光方便地诱导,并且依赖于分子碘和有机染料的组合的温和协同催化。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐